Snehal Ambre

Snehal Ambre is a Quality Control Officer at the Serum Institute of India Pvt. Ltd., specializing in the Pneumococcal Conjugate Vaccine since May 2023. Previously, Snehal served as a Research Trainee at the Indian Institute of Technology, Bombay from February 2022 to February 2023, conducting Protein Biochemistry experiments on early-stage zebrafish embryos, and also worked as a Dissertation Student, honing experimental techniques in the Vertebrate Embryogenesis Lab. Additionally, Snehal gained experience as a Research Trainee at GS Medical College & KEM Hospital in Mumbai, contributing to an Academic Clinical Trial study within the Department of Pharmacology and Therapeutics from October 2021 to December 2022. Snehal holds a Master of Science in Biotechnology from the Institute of Science, Mumbai (2020-2022), and a Bachelor of Science in Biotechnology from The KET's V. G. Vaze College of Arts, Science & Commerce (2017-2020).